Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.775
-0.075 (-4.05%)
Apr 29, 2026, 1:17 PM EDT - Market open
Gain Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 20.84 | 10.39 | 11.79 | 7.31 | 36.88 | Upgrade
|
| Short-Term Investments | - | - | 5 | 12.83 | - | Upgrade
|
| Cash & Short-Term Investments | 20.84 | 10.39 | 16.79 | 20.14 | 36.88 | Upgrade
|
| Cash Growth | 100.64% | -38.16% | -16.61% | -45.40% | 392.21% | Upgrade
|
| Other Receivables | 0.8 | 0.77 | 0.24 | 0.19 | 0.2 | Upgrade
|
| Receivables | 0.8 | 0.77 | 0.24 | 0.19 | 0.2 | Upgrade
|
| Prepaid Expenses | 0.6 | 0.45 | 0.74 | 0.76 | 0.65 | Upgrade
|
| Total Current Assets | 22.24 | 11.6 | 17.78 | 21.09 | 37.72 | Upgrade
|
| Property, Plant & Equipment | 0.41 | 0.32 | 0.59 | 0.8 | 1.01 | Upgrade
|
| Long-Term Investments | - | - | - | 1.94 | - | Upgrade
|
| Other Intangible Assets | 0.1 | 0.13 | 0.19 | 0.21 | 0.2 | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.06 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 22.82 | 12.12 | 18.61 | 24.1 | 38.99 | Upgrade
|
| Accounts Payable | 0.83 | 0.95 | 1.32 | 1.63 | 0.56 | Upgrade
|
| Accrued Expenses | 2.26 | 2.42 | 2.11 | 2 | 1.4 | Upgrade
|
| Current Portion of Long-Term Debt | 0.1 | 0.11 | 0.12 | 0.11 | 0.1 | Upgrade
|
| Current Portion of Leases | 0.12 | 0.16 | 0.23 | 0.23 | 0.22 | Upgrade
|
| Current Income Taxes Payable | 0.04 | 0.02 | 0.05 | 0.11 | 0 | Upgrade
|
| Current Unearned Revenue | - | 0.25 | 1.12 | 0.06 | 0.27 | Upgrade
|
| Total Current Liabilities | 3.35 | 3.91 | 4.95 | 4.13 | 2.55 | Upgrade
|
| Long-Term Debt | 0.3 | 0.33 | 0.45 | 0.5 | 0.59 | Upgrade
|
| Long-Term Leases | 0.21 | 0.05 | 0.23 | 0.44 | 0.7 | Upgrade
|
| Long-Term Unearned Revenue | - | 0.05 | 0.09 | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | 0.39 | 0.44 | 0.31 | 0.16 | 0.33 | Upgrade
|
| Total Liabilities | 4.25 | 4.78 | 6.03 | 5.22 | 4.17 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 119.14 | 88.78 | 73.11 | 57.36 | 55.83 | Upgrade
|
| Retained Earnings | -101.36 | -81.19 | -60.78 | -38.52 | -20.93 | Upgrade
|
| Comprehensive Income & Other | 0.78 | -0.25 | 0.25 | 0.04 | -0.09 | Upgrade
|
| Total Common Equity | 18.56 | 7.34 | 12.58 | 18.88 | 34.82 | Upgrade
|
| Shareholders' Equity | 18.56 | 7.34 | 12.58 | 18.88 | 34.82 | Upgrade
|
| Total Liabilities & Equity | 22.82 | 12.12 | 18.61 | 24.1 | 38.99 | Upgrade
|
| Total Debt | 0.73 | 0.65 | 1.03 | 1.27 | 1.61 | Upgrade
|
| Net Cash (Debt) | 20.11 | 9.73 | 15.77 | 20.81 | 35.27 | Upgrade
|
| Net Cash Growth | 106.57% | -38.27% | -24.22% | -41.01% | 466.03% | Upgrade
|
| Net Cash Per Share | 0.61 | 0.43 | 1.21 | 1.75 | 3.47 | Upgrade
|
| Filing Date Shares Outstanding | 42.24 | 27.79 | 16.22 | 11.88 | 11.88 | Upgrade
|
| Total Common Shares Outstanding | 42.07 | 27.13 | 16.21 | 11.88 | 11.88 | Upgrade
|
| Working Capital | 18.88 | 7.69 | 12.83 | 16.97 | 35.17 | Upgrade
|
| Book Value Per Share | 0.44 | 0.27 | 0.78 | 1.59 | 2.93 | Upgrade
|
| Tangible Book Value | 18.46 | 7.21 | 12.38 | 18.67 | 34.61 | Upgrade
|
| Tangible Book Value Per Share | 0.44 | 0.27 | 0.76 | 1.57 | 2.91 | Upgrade
|
| Machinery | 0.22 | 0.2 | 0.18 | 0.17 | 0.12 | Upgrade
|
| Leasehold Improvements | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.